INDAPAMIDE WATSON indapamide hemihydrate 2.5mg sugar coated tablet bottle

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

indapamide hemihydrate, Quantity: 2.5 mg

Disponibbli minn:

Medis Pharma Pty Ltd

INN (Isem Internazzjonali):

indapamide hemihydrate

Għamla farmaċewtika:

Tablet, sugar coated

Kompożizzjoni:

Excipient Ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; purified talc; calcium carbonate; titanium dioxide; sucrose; Acacia; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; Shellac; white beeswax; Carnauba Wax

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

60 tablets, 90 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Management of essential hypertension. It may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. Normally indapamide is used as the initial agent in multiple drug regimens.

Sommarju tal-prodott:

Visual Identification: White, biconvex, sugar coated tablets.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2012-04-05